Argent inks binding agreement to buy AusCann’s CannPal stake by Adam Sheldon January 15, 2026January 15, 2026 Argent BioPharma has signed a binding agreement with AusCann Group Holdings to acquire its 48% interest […]
Argent BioPharma secures A$11m facility to complete AusCann acquisition by Adam Sheldon November 17, 2025February 21, 2026
Argent BioPharma inks deal to acquire AusCann assets and IP by Martin Lane August 19, 2025August 21, 2025
Argent Biopharma and Auscann sign deal to ‘enhance drug development’ by Steve Jones April 23, 2025April 23, 2025
